Top compounds associated with response to CT47A11


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.004
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.004
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.097 0.006
mRNA alisertib CTRPv2 pan-cancer AAC -0.083 0.006
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.007
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.09 0.009
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.009
Download CSV